Processing

Please wait...

Settings

Settings

Goto Application

1. US20100151064 - Thiazolhydrazides for treatment of neurodegenerative diseases

Office United States of America
Application Number 12513480
Application Date 05.11.2007
Publication Number 20100151064
Publication Date 17.06.2010
Grant Number 08410152
Grant Date 02.04.2013
Publication Kind B2
IPC
A01N 43/78
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
72having rings with nitrogen atoms and oxygen or sulfur atoms, as ring hetero atoms
74five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
781,3-Thiazoles; Hydrogenated 1,3-thiazoles
A61K 31/425
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425Thiazoles
Applicants Mandelkow Eckhard
Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. V.
Mandelkow Eva-Maria
Technische Universitat Darmstadt
Pickhardt Markus
The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Biernat Jacek
Lloyd David George
Schmidt Boris
Larbig Gregor
Inventors Mandelkow Eckhard
Mandelkow Eva-Maria
Pickhardt Markus
Biernat Jacek
Lloyd David George
Schmidt Boris
Larbig Gregor
Agents Meyertons, Hood, Kivlin, Kowert & Goetzel, P.C.
Meyertons Eric B.
Priority Data 06022992 05.11.2006 EP
Title
(EN) Thiazolhydrazides for treatment of neurodegenerative diseases
Abstract
(EN)

Described are compounds having a thiazolhydrazide scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said thiazolhydrazide compounds can be used for prophylaxis and/or treatment of neurodegenerative diseases and conditions.

Also published as